One of the biggest hurdles to understanding Alzheimer's and other dementia Is the participation of underrepresented populations in clinical trials. When we find methods of treatment and prevention, we want them to work for all Americans. If signed into law, the bipartisan in act act, would seek to address these issues, the legislation will expand education and Outreach to underrepresented populations. Encourage the diversity of clinical trial staff. And reduce the burden of participation. Please support the enact Act.

[자막]CARLA HALL #ENDALZ Please support the Equity in Neuroscience and Alzheimer's Clinical Trials (ENACT) Act (S.1548/H.R. 3085) alzheimer's B association AIM Learn more at: alzimpact.org alzheimer's association